Status:

UNKNOWN

INTENSIVE TREATMENT WITH ROBOTIC PLUS VIBRATION IN STROKE

Lead Sponsor:

Universidad Rey Juan Carlos

Conditions:

Stroke

Activities, Motor

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The Amadeo® Manual Robotic System (Tyromotion GmbH, Graz, Austria) is designed for rehabilitative treatment of the hand and fingers providing robot-assisted exercise for the finger flexors and extenso...

Detailed Description

The rehabilitation of the stroke patient is an individual process, adapted to each type of patient, continuous and oriented by objectives whose main purpose is to treat and / or compensate for deficit...

Eligibility Criteria

Inclusion

  • Age: people aged between 30 and 80 years.
  • Diagnosis: stroke in the right hemisphere.
  • Right-handed.
  • Present hemiparesis or left hemiplegia with paralysis / paresis in his affected hand.
  • People with sensitivity alterations as a result of stroke.
  • Evolution: subacute patients (from three months to one year, and who at the same time meet the subacute criteria of the IMSERSO document of the model of care for people with brain damage, as well as chronic patients (after one year, and who meet the chronicity criteria of the IMSERSO document of the model of care for people with brain damage).
  • People without other concomitant pathologies that affect mobility and / or sensitivity
  • The acceptance and signing of the informed consent by the user.
  • Present a score equal to or greater than 24 points in the Mini-Mntal State Examination (MMSE).
  • Patients can be admitted or outpatient as long as they meet the above criteria and belong to the advanced neurorehabilitation unit.

Exclusion

  • Patients with Aphasia and / or Apraxia.
  • Patients with serious difficulties in communication.
  • Patients who do not present limitation of mobility and / or sensitivity.
  • Other concomitant diseases.
  • Diagnosis: left or posterior hemisphere stroke.
  • Scores less than 24 points on the MMSE.
  • Age over 80 years and under 30 years.
  • The non-acceptance and signing of the informed consent by the subject.
  • Evolution: acute patients less than three months of evolution.

Key Trial Info

Start Date :

March 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 15 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04762940

Start Date

March 15 2021

End Date

June 15 2021

Last Update

February 21 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad Rey Juan Carlos

Alcorcón, Madrid, Spain, 28922